JNJ-26990990 - CAS 877316-38-6

JNJ-26990990 is a broad-spectrum anticonvulsant drug and a second-generation follow-up to the marketed drug topiramate. It offers the same anticonvulsant effects as topiramate but without the side effects associated with topiramate's carbonic anhydrase inhibition. Additionally, JNJ-26990990 has potential use in treating inflammatory pain, neuropathic pain, and depression. [It] entered phase II clinical trials in October 2007.

Others, Sodium Channel, Calcium Channel

Metabolism, Others, Membrane transporter/Ion channel

877272

0.9737

C9H10N2O2S2

242.32

C(NS(N)(=O)=O)C=1C=2C(SC1)=CC=CC2

-20°C

Ice Packs

Small Compound